$Lithium South Development Corp(LIS.CA)$この資源の更新前に、これはドルに対して再評価されます。

$Patrys Ltd(PAB.AU)$
Delivery of GENE-EDITING constructs could be very lucrative for PAB . Something not priced in the share price regarding future potential.
Comment by PAB in 2022
Patrys could also become a pioneer in the emerging gene-editing
payload delivery space, giving it a lead in the gene therapy space, which is expected to see
1,500% growth by 2027, he added.

$LITHIUM SOUTH DEV CORP(LISMF.US)$
1ドルの目標価格でできます